Viewing Study NCT03616912


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2026-03-04 @ 6:35 AM
Study NCT ID: NCT03616912
Status: TERMINATED
Last Update Posted: 2023-01-30
First Post: 2018-08-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 16676
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View